LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London ...

London, 28 April 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces progress in advancing ...

London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, and Gift of Life Biologics ...

LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland London, 28 April 2025- LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and ...